Treatment of bladder cancer with embolization or chemoembolization (program ID: 688786)

University Hospital Duesseldorf

location_on Duesseldorf, Germany
9.5/10 from 71 Votes
Specialized hospital
Peter Albers

Head Physician
Prof. Dr. med.

Peter Albers

Specialized in: adult and pediatric urology

Department of Adult and Pediatric Urology

Program includes:

  • Initial presentation in the hospital
  • Clinical history taking
  • Review of available medical records
  • Physical examination
  • Laboratory tests:
    • Complete blood count
    • General urine analysis
    • Biochemical analysis of blood
    • Tumor markers
    • Inflammation indicators (CRP, ESR)
    • Coagulogram
  • Ultrasound​ scan
  • CT scan / MRI
  • Preoperative care
  • Embolization or chemoembolization, 2 procedures
  • Symptomatic treatment
  • Cost of essential medicines
  • Nursing services
  • Elaboration of further recommendations

How program is carried out

During the first visit, the doctor will conduct a clinical examination and go through the results of the available diagnostic tests. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan, CT scan and MRI. This will allow the doctor to determine which vessels are feeding the tumor and its metastases, as well as determine how well you will tolerate the procedure.

Chemoembolization begins with local anesthesia and catheterization of the femoral artery. The thin catheter is inserted through a few centimeters long incision of the blood vessel. The doctor gradually moves the catheter to the vessel feeding the primary tumor or its metastases. The procedure is carried out under visual control, an angiographic device is used for this. The vascular bed and the position of the catheter in it are displayed on the screen of the angiograph.

When the catheter reaches a suspected artery, a contrast agent is injected through it. Due to the introduction of the contrast agent, the doctor clearly sees the smallest vessels of the tumor and the surrounding healthy tissues on the screen of the angiograph. After that, he injects emboli into the tumor vessels through the same catheter.

Emboli are the spirals or the liquid microspheres. The type of embolus is selected individually, taking into account the diameter of the target vessel. When carrying out chemoembolization, a solution of a chemotherapy drug is additionally injected into the tumor vessel. Due to the subsequent closure of the vessel lumen with an embolus, the chemotherapy drug influences the tumor for a long time. In addition, the drug does not enter the systemic circulation, which allows doctors to use high doses of chemotherapeutic agents without the development of serious side effects. Chemoembolization leads to the destruction of the tumor or slowing down its progression.

After that, the catheter is removed from the artery. The doctor puts a vascular suture on the femoral artery and closes it with a sterile dressing. During chemoembolization, you will be awake. General anesthesia is not used, which significantly reduces the risks of the procedure and allows performing it on an outpatient basis, avoiding long hospital stay.

After the first procedure, you will stay under the supervision of an interventional oncologist and general practitioner. If necessary, you will receive symptomatic treatment. As a rule, a second chemoembolization procedure is performed in 3-5 days after the first one in order to consolidate the therapeutic effect. After that, you will receive recommendations for further follow-up and treatment.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)
Type of program :
Expected duration of the program:

You may also book


About the department

According to the Focus magazine, the Department of Adult and Pediatric Urology at the University Hospital Duesseldorf ranks among the top German departments specializing in prostate cancer treatment! 

The department offers the widest range of modern diagnostic and therapeutic methods for accurate detection and treatment of diseases of the genitourinary system in men and boys. The department is headed by Prof. Dr. med. Peter Albers. He is an expert in extensive operations to treat tumors, including the especially complex operations, as well as a recognized Research Fellow in Urologic Oncology. Thanks to his productive work as the Chief Physician, the department’s scientific activities thrive, while they are the basis for the introduction of the innovative, most sparing treatment methods into the clinical practice.

The priority focus of the department is the treatment of prostate cancer (certification of the German Cancer Society). Also, the department's doctors have exceptional experience in the treatment of benign prostatic hyperplasia, tumors of the bladder, kidneys, and testicles. If necessary, the surgical treatment is performed using minimally invasive, robotic interventions, and also laser technologies are widely used.

The specially trained team of doctors treats urological pathologies in children. The extensive consultations on all problems of the urological range are provided for young patients and their parents. The most common pathologies in this field are phimosis, cryptorchidism, varicocele, hypospadias, and epispadias, urinary incontinence.

The surgical service range of the department includes:

  • Laparoscopic interventions
    • Endoscopic extraperitoneal radical prostatectomy
    • Nephrectomy (including the radical nephrectomy in tumors)
    • Radical cystectomy
    • Kidney pelvis plastic repair
    • Ureterolithotomy
    • Varicocele surgery
  • Robotic surgery (DaVinci surgical system)
    • Robot-assisted endoscopic extraperitoneal radical prostatectomy
    • Robot-assisted kidney surgery
    • Robotic-assisted radical cystectomy
    • Robot-assisted kidney pelvis plastic repair
  • Endoscopic interventions
    • Rigid and flexible urethrocystoscopy
    • Rigid and flexible ureterorenoscopy
    • Ureterolitolapaxy, including laser lithotripsy
    • Percutaneous nephrolithotripsy
    • Percutaneous nephrostomy
    • Internal ureterotomy
    • Internal urethrotomy
    • Transurethral prostate resection (including holmium laser treatment (HoLEP/HoLAP))
    • Transurethral resection of bladder tumor
  • Classic surgical interventions
    • Tumor nephrectomy (access through the lumbar spine or peritoneum)
    • Kidney pelvis plastic repair
    • Urethral surgery
    • Open adenomectomy
    • Closure of the bladder or ureteral fistula
    • Nephroureterectomy with bladder cuff overlay
    • Lymph node resection in the retroperitoneal space (before and after chemotherapy)
    • Cystectomy (including orthotopic bladder substitution)
  • Other surgical interventions

Curriculum vitae

Professional Experience

  • Since 2008 and to the present day, Head of the Department of Adult and Pediatric Urology at the University Hospital Duesseldorf.
  • 2003 - 2008 Chief Physician of the Department of Urology at the Kassel Clinic.
  • 1994 - 2003 Department of Urology, University Hospital Bonn.
  • 1997 Habilitation.
  • 1991 - 1994 Research Fellow in the Department of Urology at the University Hospital Mainz, Research Internship at the German Research Foundation of the USA (Indianapolis).
  • 1988 Title of the Doctor of Medicine.

Main Focuses

  • Urologic Oncology with an emphasis on Prostate Cancer, Urothelial Cancer, Germ Cell Tumors.
  • Scientific guidance of the PROBASE on risk-adjusted PSA screening in prostate cancer screening.

Memberships and Awards

  • 2016 - 2018 President of the German Cancer Society.
  • 2012 President of the German Cancer Congress.
  • Ex-Spokesman and Board Member of the Working Group on Urological Oncology of the German Cancer Society.
  • 2008 - 2016 Representative of the Certification Commission of the Prostate Cancer Centers of the German Cancer Society.
  • Member of the European Organisation for the Research and Treatment of Cancer (EORTC).
  • 2013 - 2016 Member of the Scientific and Program Committee of the American Society of Clinical Oncology (ASCO).
  • Since 2012, Member of the Scientific Bureau of the European Association of Urology (EAU).
  • Chair of the Group for the Development of Guidelines on Testicular Cancer Treatment (EAC).
  • Member of the Movember International Research Advisory Council (testicular cancer RAC).

Photo of the doctor: (c) Universitätsklinikum Düsseldorf 

About hospital

Accommodation in hospital

There are 39 bladder cancer treatment hospitals on Booking Health website

Show all clinics


Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.